These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 16554162

  • 1. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
    Alaoui AE, Saha N, Schmidt F, Monneret C, Florent JC.
    Bioorg Med Chem; 2006 Jul 15; 14(14):5012-9. PubMed ID: 16554162
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of self-immolative glucuronide-based prodrugs of a phenol mustard.
    Lougerstay-Madec R, Florent JC, Monneret C, Nemati F, Poupon MF.
    Anticancer Drug Des; 1998 Dec 15; 13(8):995-1007. PubMed ID: 10335272
    [Abstract] [Full Text] [Related]

  • 3. Application of the ADEPT strategy to the MDR resistance in cancer chemotherapy.
    Desbene S, Van HD, Michel S, Tillequin F, Koch M, Schmidt F, Florent JC, Monneret C, Straub R, Czech J, Gerken M, Bosslet K.
    Anticancer Drug Des; 1999 Apr 15; 14(2):93-106. PubMed ID: 10405636
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT).
    Leu YL, Roffler SR, Chern JW.
    J Med Chem; 1999 Sep 09; 42(18):3623-8. PubMed ID: 10479293
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis and biological activity of protaxols.
    Nicolaou KC, Riemer C, Kerr MA, Rideout D, Wrasidlo W.
    Nature; 1993 Jul 29; 364(6436):464-6. PubMed ID: 8101355
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological evaluation of 2'-carbamate-linked and 2'-carbonate-linked prodrugs of paclitaxel: selective activation by the tumor-associated protease plasmin.
    de Groot FM, van Berkom LW, Scheeren HW.
    J Med Chem; 2000 Aug 10; 43(16):3093-102. PubMed ID: 10956217
    [Abstract] [Full Text] [Related]

  • 8. Modulating paclitaxel bioavailability for targeting prostate cancer.
    Kumar SK, Williams SA, Isaacs JT, Denmeade SR, Khan SR.
    Bioorg Med Chem; 2007 Jul 15; 15(14):4973-84. PubMed ID: 17502149
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and biological evaluation of the suberoylanilide hydroxamic acid (SAHA) beta-glucuronide and beta-galactoside for application in selective prodrug chemotherapy.
    Thomas M, Rivault F, Tranoy-Opalinski I, Roche J, Gesson JP, Papot S.
    Bioorg Med Chem Lett; 2007 Feb 15; 17(4):983-6. PubMed ID: 17157009
    [Abstract] [Full Text] [Related]

  • 11. Self-immolative nitrogen mustard prodrugs for suicide gene therapy.
    Niculescu-Duvaz D, Niculescu-Duvaz I, Friedlos F, Martin J, Spooner R, Davies L, Marais R, Springer CJ.
    J Med Chem; 1998 Dec 17; 41(26):5297-309. PubMed ID: 9857097
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy.
    Leu YL, Chen CS, Wu YJ, Chern JW.
    J Med Chem; 2008 Mar 27; 51(6):1740-6. PubMed ID: 18318465
    [Abstract] [Full Text] [Related]

  • 14. A new paclitaxel prodrug for use in ADEPT strategy.
    Bouvier E, Thirot S, Schmidt F, Monneret C.
    Org Biomol Chem; 2003 Oct 07; 1(19):3343-52. PubMed ID: 14584798
    [Abstract] [Full Text] [Related]

  • 15. A heterodimeric glucuronide prodrug for cancer tritherapy: the double role of the chemical amplifier.
    Grinda M, Clarhaut J, Tranoy-Opalinski I, Renoux B, Monvoisin A, Cronier L, Papot S.
    ChemMedChem; 2011 Dec 09; 6(12):2137-41. PubMed ID: 21815268
    [No Abstract] [Full Text] [Related]

  • 16. Development of pyrrolo[2,1-c][1,4]benzodiazepine beta-galactoside prodrugs for selective therapy of cancer by ADEPT and PMT.
    Kamal A, Tekumalla V, Krishnan A, Pal-Bhadra M, Bhadra U.
    ChemMedChem; 2008 May 09; 3(5):794-802. PubMed ID: 18247436
    [Abstract] [Full Text] [Related]

  • 17. Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy.
    Florent JC, Dong X, Gaudel G, Mitaku S, Monneret C, Gesson JP, Jacquesy JC, Mondon M, Renoux B, Andrianomenjanahary S, Michel S, Koch M, Tillequin F, Gerken M, Czech J, Straub R, Bosslet K.
    J Med Chem; 1998 Sep 10; 41(19):3572-81. PubMed ID: 9733483
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Duocarmycin-based prodrugs for cancer prodrug monotherapy.
    Tietze LF, Schuster HJ, Schmuck K, Schuberth I, Alves F.
    Bioorg Med Chem; 2008 Jun 15; 16(12):6312-8. PubMed ID: 18524605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.